AstraZeneca Licenses Silicon Genetics' Gene Expression Enterprise Solution

16-Jan-2002 - Redwood City, CA. - January 15, 2002 - Silicon Genetics, a leader in gene expression informatics solutions, today announced that AstraZeneca PLC has licensed its enterprise-wide products, GeneSpringTM, GeNetTM and Script EditorTM, designed for a genomics discovery platform. Used together, ...

Monsanto Welcomes ISAAA Report Highlighting Success for Biotech Crops in Developing World

16-Jan-2002 - ST. LOUIS (Jan.10, 2002) - Monsanto Company welcomes today's report by the International Service for the Acquisition of Agri-Biotech Applications (ISAAA), which demonstrates the growth in use of plant biotechnology around the world and its importance to improving agriculture in the developing ...

MedImmune Completes Aviron Acquisition

16-Jan-2002 - Gaithersburg, MD, January 15, 2002 -- MedImmune, Inc. announced today that it has completed its acquisition of Aviron. MedImmune acquired over 90 percent of the Aviron shares in an exchange offer which closed January 9, 2002. Earlier today, a MedImmune subsidiary merged into Aviron, as a result ...

CARDION AG expands executive board

10-Jan-2002 - Erkrath, Germany. The transatlantic biopharmaceutical company CARDION AG, with operating entities in Erkrath and Boston (USA), expanded its executive board effective January 1, 2002. In addition to CARDION´s Chief Executive Officer Dr. Michael Ruhl, Mr. Niels Ackermann and Dr. Manfred ...

GeneFormatics Forms Second Structural Proteomics Collaboration With Bristol-Myers Squibb

Companies to Develop High-Throughput NMR System to Elucidate Protein Function and Structure Information

08-Jan-2002 - San Diego, CA - January 7, 2002 - GeneFormatics, Inc., an innovator in the field of structural proteomics, today announced a collaborative partnership with Bristol-Myers Squibb Company to jointly advance the development of nuclear magnetic resonance (NMR) software for the automated, high ...

ImmunoGen, Inc. Receives Patent on Production of DM1

07-Jan-2002 - ImmunoGen, Inc. today announced that the U.S. Patent and Trademark Office has issued the Company U.S. Patent 6,333,410 B1, which covers the preparation and purification of thiol-containing maytansinoids, such as DM1. DM1 is the lead small molecule effector drug used in the Company's ...

MedImmune Receives Antitrust Clearance for Aviron Acquisition

07-Jan-2002 - Gaithersburg, MD, January 4, 2002 -- MedImmune, Inc. announced today that the waiting period regarding its acquisition of Aviron under the Hart-Scott-Rodino Antitrust Improvements Act has expired. As previously announced, MedImmune and Aviron have entered into a definitive merger agreement under ...

Amersham Biosciences Ranked Top Supplier in Proteomics Market

07-Jan-2002 - ARLINGTON, Va., Jan. 4 - Amersham Biosciences is the company that scientists most closely associate with products and services for protein science and proteomics research. Bio-Rad Laboratories ranked a close second in general awareness and was considered a leader in several categories of products ...

World's First Announcement Of Cloned 'Knock-Out' Pigs

03-Jan-2002 - PPL Therapeutics Plc, is pleased to announce it has produced 'knock-out' piglets which were born as a result of using nuclear transfer (cloning) and PPL's patented gene targeting technology. The five healthy births took place on Christmas Day, 25 December 2001. It has always been the objective of ...

New European Biotech Report From MRG, Inc. Forecasts the Growth of Bio Chip Sector to 2010

03-Jan-2002 - Sunnyvale, CA ­ January 2, 2002 ­ The biotechnology industry, notably the DNA chip and other biochip sectors, has made remarkable progress in 2001, which will also carry into 2002. While other technology sectors are showing slow to nominal growth, the biotechnology market will continue to prove ...